On Thursday, in a statement GlaxoSmithKline said, it has agreed to sell 100% of stake in Unilever’s Indian business for nearly $3.35 billion (around 254.8 billion rupees) on the open market. The development marks the British multinational pharmaceutical company cashing… Read More ›
The move is likely to be part of an economic stimulus measure following a slowdown in the Chinese economy. The move could enflare the rising bad debt, like it has in past instances of fiscal stimulus measures. On Saturday, in… Read More ›
One of the more significant reasons why Trump’s tariffs will not translate into more U.S. jobs is that consumers are not willing to pay a premium for ‘Made in USA’ goods when goods of the same quality is available for… Read More ›
manageria.biz 